-
1
-
-
84860549917
-
The FCGR2B rs10917661 polymorphism may confer susceptibility to ankylosing spondylitis in Han Chinese: A case-control study
-
Duan ZH, Pan FM, Zeng Z, Zhang TC, Wang S, Li GX, et al. The FCGR2B rs10917661 polymorphism may confer susceptibility to ankylosing spondylitis in Han Chinese: a case-control study. Scand J Rheumatol 2012;41:219-22.
-
(2012)
Scand J Rheumatol
, vol.41
, pp. 219-222
-
-
Zh, D.1
Pan, F.M.2
Zeng, Z.3
Zhang, T.C.4
Wang, S.5
Li, G.X.6
-
2
-
-
0347322146
-
Ankylosing spondylitis: An overview
-
Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002;61(Suppl 3): iii8-18.
-
(2002)
Ann Rheum Dis
, vol.61
, Issue.SUPPL. 3
-
-
Sieper, J.1
Braun, J.2
Rudwaleit, M.3
Boonen, A.4
Zink, A.5
-
3
-
-
34848886843
-
Cutting edge: The ST2 ligand IL-33 potently activates and drives maturation of human mast cells
-
Allakhverdi Z, Smith DE, Comeau MR, Delespesse G. Cutting edge: the ST2 ligand IL-33 potently activates and drives maturation of human mast cells. J Immunol 2007;179:2051-4.
-
(2007)
J Immunol
, vol.179
, pp. 2051-2054
-
-
Allakhverdi, Z.1
Smith, D.E.2
Comeau, M.R.3
Delespesse, G.4
-
4
-
-
36749067367
-
IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells
-
Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, Martin MU. IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci USA 2007;104:18660-5.
-
(2007)
Proc Natl Acad Sci USA
, vol.104
, pp. 18660-18665
-
-
Ali, S.1
Huber, M.2
Kollewe, C.3
Bischoff, S.C.4
Falk, W.5
Martin, M.U.6
-
5
-
-
61849117309
-
Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33
-
Pecaric-Petkovic T, Didichenko SA, Kaempfer S, Spiegl N, Dahinden CA. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33. Blood 2009;113:1526-34.
-
(2009)
Blood
, vol.113
, pp. 1526-1534
-
-
Pecaric-Petkovic, T.1
Didichenko, S.A.2
Kaempfer, S.3
Spiegl, N.4
Dahinden, C.A.5
-
6
-
-
65449146468
-
The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production
-
Bourgeois E, Van LP, Samson M, Diem S, Barra A, Roga S, et al. The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-gamma production. Eur J Immunol 2009;39:1046-55.
-
(2009)
Eur J Immunol
, vol.39
, pp. 1046-1055
-
-
Bourgeois, E.1
Van Lp Samson, M.2
Diem, S.3
Barra, A.4
Roga, S.5
-
7
-
-
27744446058
-
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
-
Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, McClanahan TK, et al. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 2005;23:479-90.
-
(2005)
Immunity
, vol.23
, pp. 479-490
-
-
Schmitz, J.1
Owyang, A.2
Oldham, E.3
Song, Y.4
Murphy, E.5
McClanahan, T.K.6
-
9
-
-
0032499678
-
T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function
-
Löhning M, Stroehmann A, Coyle AJ, Grogan JL, Lin S, Gutierrez-Ramos JC, et al. T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function. Proc Natl Acad Sci USA 1998;95:6930-5.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 6930-6935
-
-
Löhning, M.1
Stroehmann, A.2
Coyle, A.J.3
Grogan, J.L.4
Lin, S.5
Gutierrez-Ramos, J.C.6
-
10
-
-
80052818476
-
Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis
-
Hong YS, Moon SJ, Joo YB, Jeon CH, Cho ML, Ju JH, et al. Measurement of interleukin-33 (IL-33) and IL-33 receptors (sST2 and ST2L) in patients with rheumatoid arthritis. J Korean Med Sci 2011;26:1132-9.
-
(2011)
J Korean Med Sci
, vol.26
, pp. 1132-1139
-
-
Hong, Y.S.1
Moon, S.J.2
Joo, Y.B.3
Jeon, C.H.4
Cho, M.L.5
Ju, J.H.6
-
11
-
-
77950534152
-
Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus
-
Mok MY, Huang FP, Ip WK, Lo Y, Wong FY, Chan EY, et al. Serum levels of IL-33 and soluble ST2 and their association with disease activity in systemic lupus erythematosus. Rheumatology 2010;49:520-7.
-
(2010)
Rheumatology
, vol.49
, pp. 520-527
-
-
Mok, M.Y.1
Huang, F.P.2
Ip, W.K.3
Lo, Y.4
Wong, F.Y.5
Chan, E.Y.6
-
12
-
-
79959580694
-
Serum IL-33 levels are raised in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis
-
Yanaba K, Yoshizaki A, Asano Y, Kadono T, Sato S. Serum IL-33 levels are raised in patients with systemic sclerosis: association with extent of skin sclerosis and severity of pulmonary fibrosis. Clin Rheumatol 2011;30:825-30.
-
(2011)
Clin Rheumatol
, vol.30
, pp. 825-830
-
-
Yanaba, K.1
Yoshizaki, A.2
Asano, Y.3
Kadono, T.4
Sato, S.5
-
13
-
-
77949480323
-
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
-
Manetti M, Ibba-Manneschi L, Liakouli V, Guiducci S, Milia AF, Benelli G, et al. The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis. Ann Rheum Dis 2010;69:598-605.
-
(2010)
Ann Rheum Dis
, vol.69
, pp. 598-605
-
-
Manetti, M.1
Ibba-Manneschi, L.2
Liakouli, V.3
Guiducci, S.4
Milia, A.F.5
Benelli, G.6
-
14
-
-
0021272107
-
Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria
-
Van der Linden S, Valkenburg HA, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
-
(1984)
Arthritis Rheum
, vol.27
, pp. 361-368
-
-
Van Der Linden, S.1
Valkenburg, H.A.2
Cats, A.3
-
15
-
-
0028575453
-
A new approach to defining disease status in ankylosing spondylitis: The Bath Ankylosing Spondylitis Disease Activity Index
-
Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994;21:2286-91.
-
(1994)
J Rheumatol
, vol.21
, pp. 2286-2291
-
-
Garrett, S.1
Jenkinson, T.2
Kennedy, L.G.3
Whitelock, H.4
Gaisford, P.5
Calin, A.6
-
16
-
-
82655162052
-
Serum levels of IL-33 is increased in patients with ankylosing spondylitis
-
Han GW, Zeng LW, Liang CX, Cheng BL, Yu BS, Li HM, et al. Serum levels of IL-33 is increased in patients with ankylosing spondylitis. Clin Rheumatol 2011;30:1583-8.
-
(2011)
Clin Rheumatol
, vol.30
, pp. 1583-1588
-
-
Han, G.W.1
Zeng, L.W.2
Liang, C.X.3
Cheng, B.L.4
Yu, B.S.5
Li, H.M.6
-
17
-
-
77957883154
-
Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis
-
Mu R, Huang HQ, Li YH, Li C, Ye H, Li ZG. Elevated serum interleukin 33 is associated with autoantibody production in patients with rheumatoid arthritis. J Rheumatol 2010;37:2006-13.
-
(2010)
J Rheumatol
, vol.37
, pp. 2006-2013
-
-
Mu, R.1
Huang, H.Q.2
Li, Y.H.3
Li, C.4
Ye, H.5
Li, Z.G.6
-
18
-
-
84857447895
-
Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis
-
Xiangyang Z, Lutian Y, Lin Z, Liping X, Hui S, Jing L. Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis. Cytokine 2012;58:6-9.
-
(2012)
Cytokine
, vol.58
, pp. 6-9
-
-
Xiangyang, Z.1
Lutian, Y.2
Lin, Z.3
Liping, X.4
Hui, S.5
Jing, L.6
-
19
-
-
79958142088
-
Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population
-
Yang Z, Liang Y, Xi W, Li C, Zhong R. Association of increased serum IL-33 levels with clinical and laboratory characteristics of systemic lupus erythematosus in Chinese population. Clin Exp Med 2011;11:75-80.
-
(2011)
Clin Exp Med
, vol.11
, pp. 75-80
-
-
Yang, Z.1
Liang, Y.2
Xi, W.3
Li, C.4
Zhong, R.5
-
20
-
-
67349084096
-
IL-33-activated dendritic cells induce an atypical TH2-type response
-
Rank MA, Kobayashi T, Kozaki H, Bartemes KR, Squillace DL, Kita H. IL-33-activated dendritic cells induce an atypical TH2-type response. J Allergy Clin Immunol 2009;123:1047-54.
-
(2009)
J Allergy Clin Immunol
, vol.123
, pp. 1047-1054
-
-
Rank, M.A.1
Kobayashi, T.2
Kozaki, H.3
Bartemes, K.R.4
Squillace, D.L.5
Kita, H.6
-
21
-
-
39549100797
-
IL-33 reduces the development of atherosclerosis
-
Miller AM, Xu D, Asquith DL, Denby L, Li Y, Sattar N, et al. IL-33 reduces the development of atherosclerosis. J Exp Med 2008; 205:339-46.
-
(2008)
J Exp Med
, vol.205
, pp. 339-346
-
-
Miller, A.M.1
Xu, D.2
Asquith, D.L.3
Denby, L.4
Li, Y.5
Sattar, N.6
-
22
-
-
35348850153
-
IL-33 is a chemoattractant for human Th2 cells
-
Komai-Koma M, Xu D, Li Y, McKenzie AN, McInnes IB, Liew FY. IL-33 is a chemoattractant for human Th2 cells. Eur J Immunol 2007;37:2779-86.
-
(2007)
Eur J Immunol
, vol.37
, pp. 2779-2786
-
-
Komai-Koma, M.1
Xu, D.2
Li, Y.3
McKenzie, A.N.4
McInnes, I.B.5
Liew, F.Y.6
-
23
-
-
34147092789
-
ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis
-
Tajima S, Bando M, Ohno S, Sugiyama Y, Oshikawa K, Tominaga S, et al. ST2 gene induced by type 2 helper T cell (Th2) and proinflammatory cytokine stimuli may modulate lung injury and fibrosis. Exp Lung Res 2007;33:81-97.
-
(2007)
Exp Lung Res
, vol.33
, pp. 81-97
-
-
Tajima, S.1
Bando, M.2
Ohno, S.3
Sugiyama, Y.4
Oshikawa, K.5
Tominaga, S.6
-
24
-
-
80052510979
-
Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement
-
Manetti M, Guiducci S, Ceccarelli C, Romano E, Bellando-Randone S, Conforti ML, et al. Increased circulating levels of interleukin 33 in systemic sclerosis correlate with early disease stage and microvascular involvement. Ann Rheum Dis 2011;70:1876-8.
-
(2011)
Ann Rheum Dis
, vol.70
, pp. 1876-1878
-
-
Manetti, M.1
Guiducci, S.2
Ceccarelli, C.3
Romano, E.4
Bellando-Randone, S.5
Conforti, M.L.6
-
25
-
-
0031056613
-
Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis
-
Hasegawa M, Fujimoto M, Kikuchi K, Takehara K. Elevated serum levels of interleukin 4 (IL-4), IL-10, and IL-13 in patients with systemic sclerosis. J Rheumatol 1997;24:328-32.
-
(1997)
J Rheumatol
, vol.24
, pp. 328-332
-
-
Hasegawa, M.1
Fujimoto, M.2
Kikuchi, K.3
Takehara, K.4
-
26
-
-
0029740959
-
The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis
-
Isomäki P, Luukkainen R, Toivanen P, Punnonen J. The presence of interleukin-13 in rheumatoid synovium and its antiinflammatory effects on synovial fluid macrophages from patients with rheumatoid arthritis. Arthritis Rheum 1996;39:1693-702.
-
(1996)
Arthritis Rheum
, vol.39
, pp. 1693-1702
-
-
Isomäki, P.1
Luukkainen, R.2
Toivanen, P.3
Punnonen, J.4
-
27
-
-
79954450466
-
Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis
-
Hasegawa M, Fujimoto M, Matsushita T, Hamaguchi Y, Takehara K, Sato S. Serum chemokine and cytokine levels as indicators of disease activity in patients with systemic sclerosis. Clin Rheumatol 2011;30:231-7.
-
(2011)
Clin Rheumatol
, vol.30
, pp. 231-237
-
-
Hasegawa, M.1
Fujimoto, M.2
Matsushita, T.3
Hamaguchi, Y.4
Takehara, K.5
Sato, S.6
|